Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Nurel, Diamyd Combine GAD Technologies Through Merger

Nov. 23, 2005

By Jennifer Boggs

Solexa Raises $65M, Readies Sequencing System Launch

Nov. 22, 2005

By Jennifer Boggs

Solexa Raises $65M, Readies Sequencing System Launch

Nov. 22, 2005

By Jennifer Boggs

Gilead Reports Positive Truvada Data; FDA Probes Tamiflu Deaths

Nov. 21, 2005

By Jennifer Boggs

Vernalis Buying Cita, Picking Up Third Parkinson's Product

Nov. 21, 2005

By Jennifer Boggs

American BioScience Licenses Japanese Rights To Abraxane

Nov. 17, 2005

By Jennifer Boggs

American BioScience Licenses Japanese Rights To Abraxane

Nov. 17, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Nov. 15, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...